BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16447656)

  • 21. Cell-enhancement strategies for the treatment of ischemic heart disease.
    Seeger FH; Zeiher AM; Dimmeler S
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S110-3. PubMed ID: 17230207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cells--a clinical update.
    Tuch BE
    Aust Fam Physician; 2006 Sep; 35(9):719-21. PubMed ID: 16969445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone-marrow-derived cells and heart repair.
    Clavel C; Verfaillie CM
    Curr Opin Organ Transplant; 2008 Feb; 13(1):36-43. PubMed ID: 18660705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial regeneration by human amniotic fluid stem cells: challenges to be overcome.
    Dai W; Kloner RA
    J Mol Cell Cardiol; 2007 Apr; 42(4):730-2. PubMed ID: 17362984
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
    Kastrup J; Ripa RS; Wang Y; Jørgensen E
    Eur Heart J; 2006 Dec; 27(23):2748-54. PubMed ID: 17065171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".
    Atoui R; Shum-Tim D; Chiu RC
    Ann Thorac Surg; 2008 Jul; 86(1):327-34. PubMed ID: 18573459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac regeneration by resident stem and progenitor cells in the adult heart.
    Lyngbaek S; Schneider M; Hansen JL; Sheikh SP
    Basic Res Cardiol; 2007 Mar; 102(2):101-14. PubMed ID: 17216393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.
    Shi RZ; Li QP
    Biochem Biophys Res Commun; 2008 Nov; 376(2):247-50. PubMed ID: 18789897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The therapeutic effect of autologous bone marrow cells in ischemic heart disease].
    Hristov M; Keymel S; Weber C
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():186-9. PubMed ID: 16802551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats.
    Jiang W; Ma A; Wang T; Han K; Liu Y; Zhang Y; Zhao X; Dong A; Du Y; Huang X; Wang J; Lei X; Zheng X
    Transpl Int; 2006 Jul; 19(7):570-80. PubMed ID: 16764636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.
    Chiavegato A; Bollini S; Pozzobon M; Callegari A; Gasparotto L; Taiani J; Piccoli M; Lenzini E; Gerosa G; Vendramin I; Cozzi E; Angelini A; Iop L; Zanon GF; Atala A; De Coppi P; Sartore S
    J Mol Cell Cardiol; 2007 Apr; 42(4):746-59. PubMed ID: 17300799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of transplanted cells within the myocardium.
    Ruhparwar A; Ghodsizad A; Lichtenberg A; Karck M
    Int J Cardiol; 2008 Feb; 124(1):22-6. PubMed ID: 17442433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia.
    Bhakta S; Greco NJ; Finney MR; Scheid PE; Hoffman RD; Joseph ME; Banks JJ; Laughlin MJ; Pompili VJ
    J Invasive Cardiol; 2006 May; 18(5):212-8. PubMed ID: 16670448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell therapy for ischaemic heart disease.
    Beeres SL; Atsma DE; van Ramshorst J; Schalij MJ; Bax JJ
    Heart; 2008 Sep; 94(9):1214-26. PubMed ID: 18703700
    [No Abstract]   [Full Text] [Related]  

  • 37. The challenges of stem cell treatment in ischemic heart disease.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):289-90. PubMed ID: 19213081
    [No Abstract]   [Full Text] [Related]  

  • 38. Stem cell mechanisms and paracrine effects: potential in cardiac surgery.
    Crisostomo PR; Wang M; Markel TA; Lahm T; Abarbanell AM; Herrmann JL; Meldrum DR
    Shock; 2007 Oct; 28(4):375-83. PubMed ID: 17577135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell therapy after myocardial infarction: ready for clinical application?
    Engelmann MG; Franz WM
    Curr Opin Mol Ther; 2006 Oct; 8(5):396-414. PubMed ID: 17078382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell use for cardiac diseases as of 2008.
    Ortak J; Akin I; Kische S; Nienaber CA; Ince H
    Transfus Apher Sci; 2008 Jun; 38(3):253-60. PubMed ID: 18485824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.